Stay updated with breaking news from Nasdaq Wint. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Windtree Therapeutics, Inc. (NASDAQ:WINT – Free Report)’s stock is going to reverse split on Monday, April 22nd. The 1-18 reverse split was announced on Monday, April 22nd. The number of shares owned by shareholders will be adjusted after the market closes on Monday, April 22nd. Windtree Therapeutics Trading Down 15.3 % WINT traded down $0.06 […]
WARRINGTON, Pa., April 08, 2024 (GLOBE NEWSWIRE) -- Windtree Therapeutics, Inc. (“Windtree” or the “Company”) (NasdaqCM: WINT), today announced that on...
HC Wainwright reaffirmed their neutral rating on shares of Windtree Therapeutics (NASDAQ:WINT – Free Report) in a research report report published on Wednesday morning, Marketbeat.com reports. HC Wainwright also issued estimates for Windtree Therapeutics’ Q4 2023 earnings at ($0.94) EPS, FY2023 earnings at ($5.27) EPS and FY2024 earnings at ($0.97) EPS. Windtree Therapeutics Price Performance […]
Windtree Therapeutics, Inc. (NASDAQ:WINT – Get Free Report) was the recipient of a large growth in short interest during the month of October. As of October 15th, there was short interest totalling 188,900 shares, a growth of 540.3% from the September 30th total of 29,500 shares. Currently, 4.3% of the shares of the company are […]
Windtree Therapeutics, Inc. (NASDAQ:WINT – Get Free Report) was the target of a large increase in short interest during the month of October. As of October 15th, there was short interest totalling 188,900 shares, an increase of 540.3% from the September 30th total of 29,500 shares. Approximately 4.3% of the shares of the stock are […]